Prosecution Insights
Last updated: May 29, 2026

Hisamitsu Pharmaceutical Co. Inc.

6 pending office actions • 3 art units • 5 examiners • 0 of 6 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Portfolio Summary

6
Total Pending OAs
4
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 6 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

4
Overdue
0
Due this week
2
Due this month
0
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 6 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (4)Due ≤ 30 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
4
Medium (67%)
0
Easy (0%)
2
Unknown (33%)

Rejection Statute Mix

BucketCases
§103 only3 (50%)
§102 only1 (17%)
No statute on record2 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

5
Life Sciences
83% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
17% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
COUGHLIN, DANIEL F 2 39.2% +20.0%
CHI, AMANDA LYNN 1
ARNOLD, ERNST V 1 48.0% +12.9%
MITCHELL, EDWIN COLEMAN 1 33.3% +65.1%
KUMAR, RAKESH 1 56.9% +28.1%

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18278304 TRANSDERMAL PATCH FOR TREATING OSTEOARTHRITIS MITCHELL, EDWIN COLEMAN 103d overdue
18278279 DICLOFENAC-CONTAINING PATCH PACKAGE PRODUCT AND METHOD FOR STABILIZING DICLOFENAC SODIUM ARNOLD, ERNST V 99d overdue
18035951 METHOD FOR INHIBITING ASENAPINE DEGRADATION COUGHLIN, DANIEL F 73d overdue
18036203 ASENAPINE-CONTAINING PATCH COUGHLIN, DANIEL F 29d overdue
18270760 PACKAGING BAG AND PATCH PACKAGING PRODUCT KUMAR, RAKESH 14d

Top Art Units

Art UnitApps
1619 3
1613 2
3651 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18705656 ADHESIVE PATCH WITH COVER MATERIAL CHI, AMANDA LYNN 1613 §103 Non-Final OA 16d Pending Apr 29, 2024
18278279 DICLOFENAC-CONTAINING PATCH PACKAGE PRODUCT AND METHOD FOR STABILIZING DICLOFENAC SODIUM ARNOLD, ERNST V 1613 Other Non-Final OA 99d overdue Pending Aug 22, 2023
18278304 TRANSDERMAL PATCH FOR TREATING OSTEOARTHRITIS MITCHELL, EDWIN COLEMAN 1619 Other Non-Final OA 103d overdue Pending Aug 22, 2023
18270760 PACKAGING BAG AND PATCH PACKAGING PRODUCT KUMAR, RAKESH 3651 §103 Non-Final OA 14d Pending Jul 03, 2023
18036203 ASENAPINE-CONTAINING PATCH COUGHLIN, DANIEL F 1619 §102 Final Rejection 29d overdue Pending May 10, 2023
18035951 METHOD FOR INHIBITING ASENAPINE DEGRADATION COUGHLIN, DANIEL F 1619 §103 Final Rejection 73d overdue Pending May 09, 2023

Managing Hisamitsu Pharmaceutical Co. Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month